These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
47. Blood and plasma-based proteomic biomarker research in Alzheimer's disease. Lista S; Faltraco F; Prvulovic D; Hampel H Prog Neurobiol; 2013; 101-102():1-17. PubMed ID: 22743552 [TBL] [Abstract][Full Text] [Related]
48. Multiplexing Biomarker Methods, Proteomics and Considerations for Alzheimer's Disease. Robinson RA; Amin B; Guest PC Adv Exp Med Biol; 2017; 974():21-48. PubMed ID: 28353223 [TBL] [Abstract][Full Text] [Related]
49. Beyond statistics: a new combinatorial approach to identifying biomarker panels for the early detection and diagnosis of Alzheimer's disease. Milward EA; Moscato P; Riveros C; Johnstone DM J Alzheimers Dis; 2014; 39(1):211-7. PubMed ID: 24145380 [TBL] [Abstract][Full Text] [Related]
50. [Early evaluation of Alzheimer's disease: biomarkers and neuropsychological tests]. Lanfranco RG; Manríquez-Navarro P; Avello LG; Canales-Johnson A Rev Med Chil; 2012 Sep; 140(9):1191-200. PubMed ID: 23354643 [TBL] [Abstract][Full Text] [Related]
51. Copper in Alzheimer's disease: a meta-analysis of serum, plasma, and cerebrospinal fluid studies. Ventriglia M; Bucossi S; Panetta V; Squitti R J Alzheimers Dis; 2012; 30(4):981-4. PubMed ID: 22475798 [TBL] [Abstract][Full Text] [Related]
52. A meta-analysis of cytokines in Alzheimer's disease. Swardfager W; Lanctôt K; Rothenburg L; Wong A; Cappell J; Herrmann N Biol Psychiatry; 2010 Nov; 68(10):930-41. PubMed ID: 20692646 [TBL] [Abstract][Full Text] [Related]
53. A predictive microarray-based biomarker for early detection of Alzheimer's disease intended for clinical diagnostic application. Calciano M; Lemarié JC; Blondiaux E; Einstein R; Fehlbaum-Beurdeley P Biomarkers; 2013 May; 18(3):264-72. PubMed ID: 23557129 [TBL] [Abstract][Full Text] [Related]
54. Proteomic identification and early validation of complement 1 inhibitor and pigment epithelium-derived factor: Two novel biomarkers of Alzheimer's disease in human plasma. Cutler P; Akuffo EL; Bodnar WM; Briggs DM; Davis JB; Debouck CM; Fox SM; Gibson RA; Gormley DA; Holbrook JD; Hunter AJ; Kinsey EE; Prinjha R; Richardson JC; Roses AD; Smith MA; Tsokanas N; Willé DR; Wu W; Yates JW; Gloger IS Proteomics Clin Appl; 2008 Apr; 2(4):467-77. PubMed ID: 21136851 [TBL] [Abstract][Full Text] [Related]
55. Failure of biomarkers in clinical trials of Alzheimer's disease: blaming the messenger? Quinn J; Clark CM J Alzheimers Dis; 2009; 18(1):103-4. PubMed ID: 19625755 [No Abstract] [Full Text] [Related]
56. New lessons from the Alzheimer's Disease Neuroimaging Initiative. Salloway S Arch Neurol; 2011 Jan; 68(1):19-21. PubMed ID: 21220673 [No Abstract] [Full Text] [Related]
57. Does treating Alzheimer's disease early, delay institutionalisation? Littlewood C; Seymour J; Owen V Int J Geriatr Psychiatry; 2010 Dec; 25(12):1307-9. PubMed ID: 21086542 [No Abstract] [Full Text] [Related]
58. Early Diagnosis of Alzheimer's Disease in Blood Using a Disposable Electrochemical Microfluidic Platform. de Oliveira TR; Erbereli CR; Manzine PR; Magalhães TNC; Balthazar MLF; Cominetti MR; Faria RC ACS Sens; 2020 Apr; 5(4):1010-1019. PubMed ID: 32207606 [TBL] [Abstract][Full Text] [Related]
59. Biomarkers of Alzheimer's disease and exercise: one step closer to prevention. Yaffe K Ann Neurol; 2010 Sep; 68(3):275-6. PubMed ID: 20818785 [No Abstract] [Full Text] [Related]
60. A Multiplexed Urinary Biomarker Panel Has Potential for Alzheimer's Disease Diagnosis Using Targeted Proteomics and Machine Learning. Hällqvist J; Pinto RC; Heywood WE; Cordey J; Foulkes AJM; Slattery CF; Leckey CA; Murphy EC; Zetterberg H; Schott JM; Mills K; Paterson RW Int J Mol Sci; 2023 Sep; 24(18):. PubMed ID: 37762058 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]